- Home
- PSFE vs TVTX Comparison
PSFE vs TVTX Comparison
Compare PSFE & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSFE
- TVTX
- Stock Information
- Founded
- PSFE 1996
- TVTX 2008
- Country
- PSFE United Kingdom
- TVTX United States
- Employees
- PSFE N/A
- TVTX N/A
- Industry
- PSFE Business Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PSFE Consumer Discretionary
- TVTX Health Care
- Exchange
- PSFE Nasdaq
- TVTX Nasdaq
- Market Cap
- PSFE 770.1M
- TVTX 1.5B
- IPO Year
- PSFE N/A
- TVTX N/A
- Fundamental
- Price
- PSFE $14.06
- TVTX $23.47
- Analyst Decision
- PSFE Sell
- TVTX Strong Buy
- Analyst Count
- PSFE 4
- TVTX 16
- Target Price
- PSFE $17.38
- TVTX $35.20
- AVG Volume (30 Days)
- PSFE 263.3K
- TVTX 2.7M
- Earning Date
- PSFE 11-12-2025
- TVTX 10-30-2025
- Dividend Yield
- PSFE N/A
- TVTX N/A
- EPS Growth
- PSFE N/A
- TVTX N/A
- EPS
- PSFE N/A
- TVTX N/A
- Revenue
- PSFE $1,676,391,000.00
- TVTX $333,865,000.00
- Revenue This Year
- PSFE $3.18
- TVTX $83.26
- Revenue Next Year
- PSFE $7.05
- TVTX $43.19
- P/E Ratio
- PSFE N/A
- TVTX N/A
- Revenue Growth
- PSFE 0.47
- TVTX 87.94
- 52 Week Low
- PSFE $10.63
- TVTX $11.89
- 52 Week High
- PSFE $26.25
- TVTX $28.69
- Technical
- Relative Strength Index (RSI)
- PSFE 53.77
- TVTX 64.09
- Support Level
- PSFE $13.86
- TVTX $20.84
- Resistance Level
- PSFE $14.62
- TVTX $28.69
- Average True Range (ATR)
- PSFE 0.46
- TVTX 1.45
- MACD
- PSFE 0.01
- TVTX 0.61
- Stochastic Oscillator
- PSFE 49.74
- TVTX 55.14
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.